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Abstract
Background Severe hypoglycemia is a burdensome complication of diabetes mellitus that can induce fear of hypoglycemia and
contribute to suboptimal glycemic control. The challenge is to achieve and maintain adequate glycemic control while avoiding
episodes of severe hypoglycemia. The purpose of the study was to determine how common fear of hypoglycemia was in Zambian
out-patients with diabetes and also to explore correlates of fear of hypoglycemia.
Methods One hundred fifty-seven individuals with types 1 and 2 diabetes participated in the study. Fear of Hypoglycemia Scale,
Diabetes Self-Care Inventory, Problem Areas in Diabetes, and the Major Depression Inventory were completed. Multiple linear
regression models were computed to assess the association between fear of hypoglycemia and psychological factors.
Results About 19% [16.3% type 1 and 12.6% type 2] of individuals with diabetes based on item endorsement expressed fear of
hypoglycemia especially among individuals with type 1 diabetes. After controlling for demographic variables, diabetes self-care
(ß = 0.24, p < 0.05), and diabetes specific distress (ß = 0.41, p < 0.001) were associated with fear of hypoglycemia.
Conclusion Fear of hypoglycemia was common and was positively associated with diabetes specific emotional distress and
diabetes self-care. Interventions to avert fear of hypoglycemia are needed while optimizing glycemic control through managing
diabetes care and emotion distress in individuals with diabetes.
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Introduction
Diabetes mellitus along with hypertension are major risk fac-
tors for cardiovascular diseases. Treating these risk factors are
cost effective and can help boost productivity [1, 2]. One other
neglected complication in diabetes research in Sub Saharan
Africa is hypoglycemia. The American Diabetes Association
defines hypoglycemia as a condition characterized by abnor-
mally low blood glucose levels usually less than 70 mg/dl [3].
However, because of individual differences, it is vital to con-
sult a physician on appropriate glucose targets and what level
is low for each individual. The cause of hypoglycemia can be
either excess of diabetes medication, for example, if too much
insulin does not match the amount of carbohydrates or drinks
ingested or the levels of exercise was too much for the amount
of carbohydrates consumed. Too much alcohol can also be a
cause for hypoglycemia [4, 5]. The symptoms of hypoglyce-
mia caused by very low blood glucose levels (neurogenic
symptoms) include shaking, sweating, drowsiness, pupil dila-
tion, hunger, nausea, anxiety, palpitations, and headache.
Other symptoms (neuroglycopenic systems) include poor
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motor coordination, confusion, negative mood state,
argumentativeness and irritability, seizures, coma, and even
death if severe hypoglycemia remains untreated [6, 7].
Moreover, cognitive difficulties have been linked to early ill-
ness onset and illness duration, recurrent hypoglycemic epi-
sodes, and hypoglycemia especially in children with diabetes
[8, 9]. A global study involving 24 countries found that hypo-
glycemia is common (2.5 per person/year) in individuals with
type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus
(T2DM) using insulin therapy and that it is one of the leading
reasons for hospitalization for individuals with diabetes [10].
For instance, in a study in South Africa with 43 patients that
were admitted at Baragwanath Hospital in Soweto, a total of
51 episodes of hypoglycemia in a 5-month period were re-
corded [11]. Hypoglycemia has a burden on healthcare utili-
zation, costs, and quality of life [12]. While data shows
hypolycemia is common, little is known how common fear
of hypoglycemia is in Zambia. Unlike in developed countries,
many SSA countries have weak diabetes health care, as such,
investigating fear of hypoglycemia and its correlates remains
important as it is an indicator of glycemic control and
diabetes-related quality of life.
One of the challenges in the treatment of diabetes is to achieve
optimal glycemic control while avoiding episodes of hyperglycemia
or hypoglycemia [6]. Onemajor downside of near normal glycemic
controls is the elevated risk for hypoglycemia [13, 14]. Given the
unpleasant aspects of hypoglycemia and the potentially life-
threatening nature of severe hypoglycemia, many people with dia-
betes have significant fears of developing hypoglycemia [15]. Over
time, FoH is triggered by hypoglycemia unawareness (HU). HU is
defined at the onset of neuroglycopenia before the appearance of
autonomic warning symptoms [16]. Enough evidence including
data from systematic reviews shows that fear of hypoglycemia
(FoH) is associated with being female [17–19], being old [17, 19],
young age as reported by parents for children with type 1 diabetes
[20], psychosocial factors such as anxiety, stress, depression, and
impaired quality of life (QoL) [11, 19], whereas mixed results were
found for the association of FoH with BMI [21]. FoH is also pos-
itively associated with duration of diabetes [17, 22], diabetes com-
plications [18], and the individual’s history of hypoglycemia espe-
cially severe episodes [12, 15].
FoH can adversely affect QoL, emotional wellbeing, diabetes
management, and glycemic control in people with diabetes, yet
few studies have been conducted on the subject in Africa, and
these studies tend to be epidemiological in nature [11, 23]. For
instance, a study with a sample of 43 South African patients,
reported a total of 51 episodes of hypoglycemia in a period of 5
months [11]. Hypoglycemia has been observed to range between
25 and 55% in Sub-Saharan African diabetes patients per year
[23]. Given that severe hypoglycemia is one of the leading reasons
for hospitalization inAfrican patientswith diabetes, studies explor-
ing FoH and factors associated with it are warranted. Identifying
FoH and specific factors associated with FoH are important for
developing parsimonious interventions. The aim of this study was
to investigate how commonFoH is and factors relatedwith FoH in
out-patients with type 1 diabetes and type 2 diabetes mellitus.
Methods
Design
This study employed a cross-sectional design. We assessed
the association between the independent variables of interest
(e.g., diabetes self-care, depression, and diabetes specific
emotional distress) and the dependent variable, fear of hypo-
glycemia while controlling demographic variables.
Study sample
The study sample comprised of outpatients with either type 1
diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM)
who were either on insulin or oral treatment from major hos-
pitals in Lusaka (University Teaching Hospital), Ndola
(Arthur Davison Children’s Hospital, Kitwe (Kitwe Central
Hospital), and Livingstone (Livingstone General Hospital).
Convenience sampling was used to recruit patients in the
study as long as they were at least 12 years old and were
diagnosed at least 6 months before the study to allow for
manifestation of psychological challenges. The exclusion
criteria included anyone who was not yet on any diabetes
medicine, diagnosed less than 6 months and were below 12
year of age. In total 157 patients signed the consent form and
were recruited over a 1-year period.
Measures
The measures were administered in English and in 2 local
languages, namelyNyanja and Bemba. Back translations were
done by two native speakers in each language whowere fluent
in the other language and English. The translators met to dis-
cuss the translation together with the first author to discuss the
translation in each language and the differences between for-
ward and back translation versions. The goal was to maximize
both linguistic and psychological equivalence. All measures
were chosen for use in this study based on their good psycho-
metric properties.
Demographic variables Age, sex, education level, SES (as
evaluated using proxy measures of properties and services
owned by families of participants) and diabetes type. In addi-
tion, the body mass index of the participants was calculated
using height and weight.
Fear of hypoglycemia The Hypoglycaemia Fear Survey (HFS)
consists of 26 items. HFS comprises two scales assessing “worries
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about hypoglycaemia” and “hypoglycaemia-related behaviors.”
The items are rated on a 5-point scale ranging from 1 (never) to
5 (very often). A Cronbach’s alpha of 0.90 suggests high internal
consistency [24]. In the current study alpha was 0.80 (Lambda2 =
0.81). A pilot study on 6 adolescents with T1DM confirmed item
comprehension by the participants. Extreme scores indicate FoH
(possible range 26–130) [11]. In order to examine the proportion
of individualswith high frequency ofworries about hypoglycemia,
the point scales “1 = never and 2 = rarely”were considered “rarely
do,” the scale “3 = sometimes” remained sometimes while the
scales “4 = often and 5 very often” were considered “often do”
in the current study.
Diabetes-specific emotional distress The PAID is a 20-item
self-report measure used to assess diabetes-specific emotional
distress, including a range of feelings such as diabetes-related
anger, fear, depression, worry, and guilt. Items can be
responded to on a scale from 0 (not a problem) to 4 (serious
problem). An overall score for the PAID can be calculated by
adding all of the item scores and multiplying by 1.25, which
gives a total score ranging from 0 to 100. Higher scores indi-
cate more distress. Reported Cronbach’s alphas for the PAID
ranges from 0.84 to 0.96 [25–34]. In the current study the
alpha was 0.88 (Lambda2 = 0.89).
Diabetes self-care The 13 item Self-Care Inventory (SCI) is a
self-report measure used to assess patients' perceptions of their
adherence to diabetes self-care recommendations over the pre-
vious 1 month. Individuals rate themselves on a 5-point Likert
scale that reflects on how well they followed recommenda-
tions for self-care during the past month (i.e., 1 = “never do it”
to 5 = “always do this as recommended, without fail”). Higher
scores indicate more optimal diabetes self-care. Cronbach’s
alpha for the SCI was 0.84 (Lambda2 = 0.85) for T1DM
and 0.85 (lambda2 = 0.86) for T2DM [35]
Depression The Major Depression Inventory (MDI) is a 12-
item self-report questionnaire used to assess depression. Items
of the MDI asked of the patient to rate how long in the past 2
weeks each of the depressive symptoms was present on a six-
point scale ranging from 0 “not at all” to 5 "all time". It can be
used as an instrument measuring severity of depression with a
range from 0 - 60. The internal consistency of the MDI ap-
peared to be good as indicated by Cronbach alphas ranging
from 0.89 to 0.94 [36, 37]. In the current study, Cronbach
alpha was 0.80 (Lambda2 = 0.81).
Statistical analysis
Descriptive statistics including means (standard devia-
tions), frequencies, and percentages were computed. We
used the item endorsement criteria recommended by
Hajos et al. to determine the proportion of individuals with
elevated fear of hypoglycemia [38]. The Mann-Whitney U
test was conducted to examine the mean rank differences
between the two types of diabetes and individual items of
the FoH scale. Independent t tests were conducted to ex-
amine mean difference between the two types of diabetes
on the total score of the FoH Scale and on the two dimen-
sions (behavior and worry) of the scale. Multiple linear
regression models were conducted to assess the association
between the total score of the FoH scale and the two di-
mensions of the scale as the criterion variables with other
predictor variables, including diabetes self-care, diabetes
specific-emotional distress, depressive symptoms, age,
type of diabetes, sex, socioeconomic status (SES), and
body mass index (BMI). Statistical significance was set at
p < 0.05. BMI was computed in SPSS using the following
formula: weight (kg)/[height (m)]2.
Results
Demographic data
Of the 157 participants, 80 were females (51%). We did not
find significant differences in gender composition of the pa-
tients with T1DM or T2DM. Mean age was 39 ± 17 years,
ranging from 12 to 68 years. Of the total sample, 115 (73%)
were adults and 42 (27%) adolescents. Table 1 shows the
detailed demographic characteristics of the participants.
Proportions of fear of hypoglycemia
About 19% of the sample endorsed 4 “often” and 5 “very
often” worry on the scale indicating elevated FoH. The
general pattern showed that individuals with T1DM
(16.3%) had more FoH than individuals with T2DM
(12.6%) (Table 2), although this difference was not statis-
tically significant on the full scale or the two dimensions:
behavior and worry (Table 2). At the item level, under the
behavior dimension of the FoH, only one item was statis-
tically significant: individuals with type 1 diabetes were
significantly more likely to carry fast acting sugar with
them (U = 1938.50, p < 0.01) (Table 3). On the worry
dimension of the FHS, appearing stupid or drunk (U =
2347.00, p < 0.05), got bad evaluation at school/work be-
cause of something that happened when blood glucose was
low (U = 1722.50, p < 0.001), and having an insulin reac-
tion (U = 2234.50, p < 0.05) were reported more in T1DM
individuals compared to T2DM individuals. Making a
mistake/accident while at school or work (U = 2336.00, p
< 0.056) bordered on significance (Table 2).
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Factors associated with fear of hypoglycemia
Multiple linear regression showed that after adjusting for
background variables, there was a positive association be-
tween FoH and higher diabetes self-care scores (β = 0.20, p
< 0. 05). Higher levels of diabetes specific-emotional distress
(β = 0.40, p < 0.001), and higher levels of depressive symp-
toms (β = 0.10, p < 0.05) were associated with higher FoH.
Among the adjusted variables, younger age was associated
with more FoH (β = − 0.26, p < 0.05). In the second model
involving the behavior dimension of the FoH, a higher
diabetes self-care score was associated with more FoH (β =
0.24, p < 0.01). For the adjusted variables, younger age was
the only one associated with increased FoH (β = − 0.36, p <
0.01) while a higher socioeconomic status was associated with
more FoH (β = 0.21, p < 0.05). In the third model involving
the worry dimension, FoH was associated with higher
diabetes-specific emotional distress (β = 0.46, p < 0.001)
and depressive symptoms (β = 0.21, p < 0.01). Having
T1DM (as opposed to having T2DM) was the only back-
ground variable that was associated with higher FoH-worry
dimension (Table 4).
Discussion
The aim of this study was to find out to how common FoH is
in people with diabetes in Zambia, and also to explore corre-
lates of FoH. About 19% [16.3% T1DM and 12.6% T2DM]
of individuals with diabetes in Zambia reported elevated FoH.
Our results are slightly lower, compared to those reported in
an epidemiological study (25–55%) in Sub-Saharan African
T1DM patients and 798 T2DM patients in Helsinki, Finland
(52.5% all, 43% men, and 62% women) [23, 39]. The mean
scores for Zambians living with diabetes were somewhat low-
er (57.38 ± 12.34) compared to a sample of insulin-dependent
diabetes patients aged 18–80 years in the USA and India. It is
important to realize the potential pitfalls of the comparisons
(e.g., incomparable background characteristics of samples,
differential appropriateness of the instrument across the
USA and Zambia, sample size or other assessment bias is-
sues). Still, across all countries, past experience of hypogly-
cemia, or unrecognizable condition can cause fear. It could be
that participants in our study experienced less frequent severe
hypoglycemic episodes, because of deliberate suboptimal di-
abetes care in order to avoid hypoglycemia because hypogly-
cemia can result from exogenous or endogenous insulin ex-
cess alone, hence some patients do a trade-off between good
self-care or avoiding hypoglycemia; unfortunately, data on
severe hypoglycemic events were lacking. Hypoglycemia
has long been recognized to be a major limitation in achieving
good control especially in T1DM, although with the increas-
ing use of insulin to treat T2DM, the actual prevalence of
hypoglycemia is likely to escalate [40]. Moreover, our SCI
mean scores show suboptimal diabetes self-care in both types
of diabetes. Our data showed individuals with T1DM seemed
to FoH more compared to individuals with T2DM as expect-
ed. Specifically, individuals with type 1 carried more fast-
acting sugar (behavior dimension), were more worried to ap-
pear stupid or drunk, making a mistake/accident at school/
work, getting a bad evaluation at school/work because of
something that happened when sugar was low and they wor-
ried more on having an insulin reaction.
Table 1 Demographic and clinical characteristics of 157 participants
with type 1 and type 2 diabetes
Sex, n (%)
Females 80 (51%)
Age, mean (SD) 39±17
Age range 12-68 years
Location of patients
Lusaka 48 (31%)
Kitwe 60 (38%)
Ndola 35 (22%)
Livingstone 14 (9%)
Developmental stage n (%)
Adolescents 42 (27%)
Adults 115 (73%)
Educational levels n (%)
Adolescents (42)
5-7th Grade (Primary school) 14 (31%)
8-12th Grade (Secondary school) 16 (38%)
Missing 14 (31%)
Adults (115)
Primary education 10 (9%)
Secondary education 29 (25%)
Tertiary education 22 (19%)
Missing 54 (47%)
Marital status (Adults/115) n (%)
Single 6 (5%)
Married 80 (70%)
Missing 29 (25%)
Type of diabetes
Type 1 93(59)
Type 2 58 (37)
Missing (either type 1or 2) 6 (4)
BMI mean (SD) 25 (5) kg/m2
Males 25 (5) kg/m2
Females 26 (5) kg/m2
Adolescents 22 (4) kg/m2
Adults 27 (5) kg/m2
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Table 2 Proportions of engaging
in diabetes-related control
measures to avoid hypoglycemia
and frequent worries for
hypoglycemia
Frequency (%) Mean rank (p-values)
Item Description Never
do
Sometimes Often
do
TIDM vs.
T2DM
Behavior dimension
Eat large snack at bed time 125(80) 19(12) 13(8) 75.83
vs.77.56
(>0.05)
Avoid being alone when sugar is likely to be
low
62(40) 58(37) 37(23) 75.39
vs.78.25
(>0.05)
…little sugar to be on the safe side 94(60) 44(28) 19(12) 78.64
vs.73.25
(>0.05)
Keep my sugar high when I will be alone for
a while
109(69) 17(11) 31(20) 74.35
vs.79.89
(>0.05)
Eat something as soon as I feel sign of low
blood sugar
27(17) 50(32) 80(51) 80.84 vs.
69.65
(>0.05)
Reduce my medication when I think sugar is
too low
77(50) 23(14) 57(36) 75.58 vs.
77.96
(>0.05)
Keep my sugar higher when I plan to be in a
long activity
104(66) 23(15) 30(19) 74.45
vs.79.96
(>0.05)
Carry fast acting sugar with me 88(56) 39(25) 30(10) 85.16
vs.62.86
(<0.01)
Avoid a lot of exercising when I think my
sugar is low
63(40) 42(27) 52(33) 80.04
vs.70.92
(>0.05)
Check my sugar often when I plan to be in a
long activity
71(45) 26(17) 60(38) 80.52 vs.
70.16
(>0.05)
Worry dimension
Not recognising/realizing I am having a
reaction
71(45) 56(36) 30(19) 77.89
vs.74.35
(>0.05)
Not having food, fruit or juice with me 73(47) 56(35) 28(18) 78.58
vs.73.22
(>0.05)
Feeling dizzy or passing out in public 91(58) 44(28) 22(14) 73.33 vs.
81.50
(>0.05)
Having a reaction while asleep 84(52) 50(32) 25(16) 73.36 vs.
81.45
(>0.05)
Embarrassing myself/family in social
situations
122(78) 25(16) 10(6) 79.40
vs.71.92
(>0.05)
Having a reaction while alone 92(59) 55(35) 10(6) 75.08
vs.78.75
(>0.05)
Appearing stupid or drunk 141(90) 14(9) 2(1) 80.76 vs.
69.78
(<0.05)
Losing control 95(60) 53(34) 9(6) 79.75 vs.
71.37
(>0.05)
No one being around to help me during a
reaction
84(54) 58(37) 15(9) 76.15
vs.77.05
(>0.05)
Making a mistake/accident at school/work 130(83) 19(12) 8(5) 80.88 vs.
69.59
(>0.05)†
Getting a bad evaluation at school/work
because something…
123(78) 20(13) 14(9) 87.48
vs.59.19
(<0.001)
Having seizures or convulsions 130(83) 22(14) 5(3) 80.41
vs.70.33
(>0.05)
Difficulty thinking clearly when responsible
for others.
95(57) 49(31) 18(12) 77.68 vs.
74.64
(>0.05)
Developing long term complications from
freq.low blood
115(73) 32(21) 10(6) 78.93
vs.72.67
(>0.05)
Feeling lightheaded or faint 91(58) 48(30) 18(12) 76.88
vs.75.91
(>0.05)
Having an insulin reactions 112(71) 36(23) 9(6) 81.97
vs.67.87
(<0.05)
†Marginal (0.56), scale 1&2 = “never do”, 3 = “sometimes”, 4 &5 = “often do”. Significant differences in bold.
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The study looked at the associations between FoH and
psychological constructs in the first model, and in the second
and third model, the study looked at the associations between
the two dimensions of FoH (behavior and worry) and a num-
ber of psychological constructs. In the first model, FoH was
associated with increased diabetes care. Significant evidence
shows that improved glycemic control i.e, lowering of average
glucose, is associated with increased occurrence of hypogly-
cemia [19, 41]. The relationship between hypoglycemia and
diabetes self-care particularly glycemic control is that of “you
gain one and lose one.” People with diabetes need to navigate
their ship between two seamonsters, one named Scylla, the
other Charybdis. Scylla is sitting on a rock (hyperglycemia),
the other monster Charybdis creates a whirlpool
(hypoglycemia).
Increased diabetes-specific distress (PAID) was also asso-
ciated with increased FoH. People living with diabetes are
often confronted with stressors that can affect diabetes care
and contribute to FoH. Surprisingly, depression was not asso-
ciated with FoH at least in this model. Of the controlled back-
ground variables, being young was associated with FoH. Our
study confirms previous findings suggesting that younger age
is associated with FoH [17, 20] although elsewhere older peo-
ple showed more fear [15, 19, 42].
The behavior dimension of the FoH was only associated
with diabetes self-care. However, among background vari-
ables, higher socioeconomic status and younger age of pa-
tients was associated with FoH. The behavior dimension of
FoH involves crucial self-care activities useful for glycemic
control. Perhaps patients from high SES engage in social ac-
tivities that distract them from self-care activities such as
drinking alcohol which has been found to be a risk factor.
Moreover, the best way to control hypoglycemia is through
a diet similar to that used to control diabetes mellitus: a reduc-
tion in simple sugars, a large intake of complex carbohydrates,
and frequent feedings. It could be that those from high SES
have easy access to candy, sodas, and even fruit juices (which
manufacturers often sweeten with lots of sugar) all high in
sugar and should be avoided. Future research should explore
this association further.
Not surprising, the worry dimension of the FoH was associ-
ated with diabetes-specific distress and depressive symptoms.
Hypoglycemia adversely alters mood, and recurrent hypogly-
cemia elevates anxiety and depression [43]. Depressive symp-
toms and selective serotonin reuptake inhibitors are associated
with progressively increased risks of hypoglycemia [44].
An interesting pattern of association emerged from our data.
The behavior dimension of the FoH was associated with more
Table 4 Predictors of fear for hypoglycemia
Model 1: FoH total scale Model 2: FoH Behavior dimension Model 3: Worry dimension
Variables Beta p-value Beta p-value Beta p-value
Age -.26 0.02* -.36 0.00*** -.10 0.33
Being female .02 0.79 -.06 0.47 .08 0.33
Having type 2 diabetes .10 0.30 .06 0.53 -.18 0.04*
Socioeconomic status .06 0.47 .20 0.02* -.07 0.41
Body mass index .14 0.17 .07 0.49 .14 0.14
Diabetes self-care .20 0.02* .24 0.01** .12 0.16
Diabetes-specific emotional distress .41 0.001*** .15 0.13 .46 0.001***
Depressive symptoms .19 0.17 .09 0.36 .21 0.02*
R2 = .27, Adj R2 = .22 R2 = .18, Adj R2 = .12 R2 = .33, Adj R2 = .28
*p <0.05, **p <0.01, ***p < 0.001
Table 3 Fear of hypoglycemia,
PAID, DSC, and MDI mean (and
SDs) for the two types of diabetes
All types Type 1 diabetes Type 2 diabetes p-value
Fear of hypoglycaemia (total) 57.38 (12.34) 59.02 (12.71) 55.17 (11.23) > 0.05
Behavior dimension 25.01 (6.43) 25.42 (6.53) 24.11 (6.26) > 0.05
Worry dimension 33.37 (8.63) 33.60 (9.08) 31.06 (7.35) >0 .05
Diabetes self-care 44.18 (9.05) 43.10 (8.93) 45.06 (8.93) >0 .05
PAID 40.28 (18.62) 39.72 (19.09) 42.33 (17.81) > 0.05
Depression (MDI) 29.44 (9.18) 28.56 (9.86) 31.18 (8.16) >0 .05
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constructs such as diabetes self-care activities and socioeconomic
status whereas the worry dimension relates to more psychologi-
cal constructs such as depression and diabetes specific distress.
Young people were more likely to have fear of hypoglycemia
based on the behavior dimensions of the scale while individuals
with T2DM (all adults in this study) were likely to have FoH
based on the worry dimension of the scale. At the item level,
having T1DM compared to T2DMwas associated with carrying
fast acting sugar, appearing stupid or drunk, making a mistake or
having an accident at school or work and getting bad evaluation
at school because of something that happened when sugar was
low. These results were not surprising given that T1DM is the
onewhich is more prone to hypoglycemia and hasmore self-care
demands than T2DM.Moreover, the developmental age of indi-
viduals with T1DM are the ones below 18 years of age (also the
case in this study) which complicates the balance between dia-
betes self-care and avoiding hypoglycemia.
The strength of the study is that we were able to assess
FoH in both T1DM and T2DM. Most studies examine the
two types of diabetes separately making it difficult to
make comparison. Limitations of the study are that we
do not know the refusal rate; therefore, there might have
been a selection-bias. The sample size was also small due
to recruitment difficulties; as a consequence, probability
sampling could not be used. Another limitation is that data
on HbA1c, type of medication for T2DM patients (oral or
insulin), and number of severe and frequency of hypogly-
cemia in the past year were lacking. However, despite
these limitations, this study still remains important as it
shed lights on psychosocial factors associated with FoH
in a country with little information on FoH in diabetes
patients. Therefore, this study will suggest directions for
future studies on the mechanism influencing FoH in
Zambia and other SSA countries. Future studies on fear
of hypoglycemia should be complimented by interviews
to individuals with diabetes and adults living with individ-
uals with diabetes.
In conclusion, FoH was common in individuals with dia-
betes in Zambia. FoH is positively associated with diabetes
specific emotional distress and diabetes self-care. Therefore,
physicians need to assess fear of hypoglycemia based on its
dimensions since they seem to be associated with demograph-
ic characteristics and psychosocial issues differently.
Physician need to consider depression, self-care, diabetes-
specific distress, younger age, higher SES, and T1DM when
intervening on fear of hypoglycemia.
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